GlassScriptPhysician profile
Sisir Siddamsetti
NPI 1790169787
$44,158.89
in general payments reported to CMS, 2019-2025
19 companies · $3,407 in 2025
The $3,407 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $657 · 2021: $397 · 2022: $9,259 · 2023: $22K · 2024: $8,235 · 2025: $3,407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $13K · Grant: $12K · Food and Beverage: $8,459 · Education: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $12,826.49 |
| Grant | $12,083.33 |
| Food and Beverage | $8,458.77 |
| Education | $237.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18,530.84 | 2021-2025 | Micra, Evera Mri Xt Dr Surescan, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $12,731.51 | 2019-2025 | Ensite Precision, Advisor, Ensite |
| Boston Scientific Corporation | $8,766.92 | 2019-2025 | Versacross Access Solution, Watchman Access System, Watchman Flx |
| Medical Device Business Services, INC. | $1,434.34 | 2023-2024 | Carto 3 |
| Biosense Webster, INC. | $1,200.46 | 2023-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter |
| Biotronik INC. | $543.65 | 2022-2025 | Acticor 7 Vr-T Dx |
| Amgen INC. | $287.87 | 2019-2025 | Repatha |
| Medtronic Vascular, INC. | $281.87 | 2020 | |
| Atricure, INC. | $97.17 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $80.03 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $54.67 | 2022-2025 | |
| Kestra Medical Technology Services, INC. | $39.68 | 2025 | Assure Wcd |
| Esperion Therapeutics, INC. | $20.38 | 2025 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $18.45 | 2024 | Camzyos |
| Chiesi USA, INC. | $17.82 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.86 | 2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $14.46 | 2025 | Lokelma |
| Lantheus Medical Imaging, INC. | $12.50 | 2019 | |
| Pfizer INC. | $11.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sisir Siddamsetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.